I. GOALS AND OVERVIEW The goal of the Career Development Award Program is to attract basic, translational and clinical investigators into skin cancer research, to provide them with information about human skin cancer, mentor them in their chosen career pathways, and integrate the recipients into the translational mission of the SPORE. Many investigators within the BWH Skin Cancer SPORE have longstanding interest and a substantial track record of mentoring and developing of junior faculty. This Program establishes a formal process for the identification, selection, funding and mentoring of young investigators seeking to pursue careers in Skin cancer research. The Career Development Program will be funded at $100,000 per year, with $55,000 being requested from the NIH in this competitive renewal application, and $45,000 deriving from institutional support. The intent is to fund one or two awardees per year. Individual awardees may receive funds over a single year or multiple years as fits their needs. Candidates for this award can be at several levels of training: senior level postdoctoral fellows who are moving into faculty status and instructor level junior faculty within three years of completing their training who are interested in pursuing hypothesis-driven research. The typical applicant is a junior faculty member with a strong program of research, a secure position in a mentoring environment, and the need for funding as a bridge to independence. Consideration is also given to established investigators interested in shifting their research focus to skin cancer. A process of nomination, application and committee review will generally be used to distribute the awards. On occasion, the Principal Investigator may recommend appointment (for instance if funds become available off-schedule). The purpose of the nominating process (senior faculty recommending junior faculty) is to assure the day-to-day presence of a mentor for the award recipients. Senior faculty are eligible to apply if they are not members of the Melanoma and Cutaneous Oncology Program in the Dana-Farber Harvard Cancer Center (DFHCC), seek association with the SPORE and have a promising project that would benefit from SPORE membership. In practice, award recipients should attend SPORE functions, use SPORE Cores, and meet with Dr. Kupper on a regular basis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA093683-09
Application #
8332869
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-08-01
Budget End
2012-07-31
Support Year
9
Fiscal Year
2011
Total Cost
$55,691
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
030811269
City
Boston
State
MA
Country
United States
Zip Code
02115
de Masson, Adele; O'Malley, John T; Elco, Christopher P et al. (2018) High-throughput sequencing of the T cell receptor ? gene identifies aggressive early-stage mycosis fungoides. Sci Transl Med 10:
Sung, Hyeran; Kanchi, Krishna L; Wang, Xue et al. (2016) Inactivation of RASA1 promotes melanoma tumorigenesis via R-Ras activation. Oncotarget 7:23885-96
Kirsch, Ilan R; Watanabe, Rei; O'Malley, John T et al. (2015) TCR sequencing facilitates diagnosis and identifies mature T cells as the cell of origin in CTCL. Sci Transl Med 7:308ra158
Lee, Jonathan J; Granter, Scott R; Laga, Alvaro C et al. (2015) 5-Hydroxymethylcytosine expression in metastatic melanoma versus nodal nevus in sentinel lymph node biopsies. Mod Pathol 28:218-29
Ma, Jie; Frank, Markus H (2015) Isolation of Circulating Melanoma Cells. Methods Mol Biol :
Jain, Salvia; Stroopinsky, Dina; Yin, Li et al. (2015) Mucin 1 is a potential therapeutic target in cutaneous T-cell lymphoma. Blood 126:354-62
Watanabe, Rei; Gehad, Ahmed; Yang, Chao et al. (2015) Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Sci Transl Med 7:279ra39
Lee, Jonathan J; Cook, Martin; Mihm, Martin C et al. (2015) Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma. Oncotarget 6:37995-8004
Bhela, Siddheshvar; Kempsell, Christine; Manohar, Monali et al. (2015) Nonapoptotic and extracellular activity of granzyme B mediates resistance to regulatory T cell (Treg) suppression by HLA-DR-CD25hiCD127lo Tregs in multiple sclerosis and in response to IL-6. J Immunol 194:2180-9
Lee, Jonathan J; Sholl, Lynette M; Lindeman, Neal I et al. (2015) Targeted next-generation sequencing reveals high frequency of mutations in epigenetic regulators across treatment-naïve patient melanomas. Clin Epigenetics 7:59

Showing the most recent 10 out of 132 publications